Treatment of pyoderma gangrenosum with the anti-TNFα drug – Etanercept

Reichrath, 2005, Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients, J Am Acad Dermatol, 53, 273, 10.1016/j.jaad.2004.10.006 Trent, 2005, Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases, Dermatol Nurs, 17, 97 McGowan, 2004, Treatment of pyoderma gangrenosum with Etanercept, J Drugs Dermatol, 3, 441 Niezgoda, 2006, Managing pyoderma gangrenosum: a synergistic approach combining surgical debridement, vacuum-assisted closure, and hyperbaric oxygen therapy, Plast Reconstr Surg, 117, 24, 10.1097/01.prs.0000200776.13868.02 Pastor, 2005, Pyoderma gangrenosum treated with anti-TNF alpha therapy (Etanercept), Clin Exp Dermatol, 31, 152, 10.1111/j.1365-2230.2005.01972.x